Symbols / ZYBT Stock $0.92 +0.00% Zhengye Biotechnology Holding Limited

Healthcare • Drug Manufacturers - Specialty & Generic • China • NCM
ZYBT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Songlin Song
Exch · Country NCM · China
Market Cap 43.60M
Enterprise Value 145.53M
Income -19.37M
Sales 153.74M
FCF (ttm) 24.23M
Book/sh 0.91
Cash/sh 1.00
Employees 277
Insider 10d —
IPO Jan 07, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 0.28
P/B 1.01
P/C —
EV/EBITDA -65.76
EV/Sales 0.95
Quick Ratio 1.00
Current Ratio 1.49
Debt/Eq 23.49
LT Debt/Eq —
EPS (ttm) -0.22
EPS next Y —
EPS Growth —
Revenue Growth -34.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -3.45%
ROE -6.38%
ROIC —
Gross Margin 37.37%
Oper. Margin -46.33%
Profit Margin -12.60%
Shs Outstand 47.39M
Shs Float 4.42M
Insider Own 3.94%
Instit Own 2.10%
Short Float 1.15%
Short Ratio 0.09
Short Interest 51.12K
52W High 13.97
vs 52W High -93.41%
52W Low 0.68
vs 52W Low 35.29%
Beta —
Impl. Vol. —
Rel Volume 0.03
Avg Volume 217.23K
Volume 6.82K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.92
Price $0.92
Change 0.00%
About

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.92
Latest analyst target
3. DCF / Fair value
$9.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.92
Low
—
High
—
Mean
—
News
RSS: Latest ZYBT news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
116.36
-37.56%
186.36
-11.95%
211.65
-18.68%
260.27
Operating Revenue
102.62
-40.78%
173.29
-15.20%
204.35
-18.90%
251.98
Cost Of Revenue
92.49
-2.70%
95.06
+0.98%
94.14
-16.24%
112.39
Reconciled Cost Of Revenue
92.49
-2.70%
95.06
+0.98%
94.14
-16.24%
112.39
Gross Profit
23.87
-73.86%
91.30
-22.31%
117.51
-20.54%
147.88
Operating Expense
92.12
+24.28%
74.12
+6.09%
69.87
-14.58%
81.79
Research And Development
18.01
+40.79%
12.79
+7.50%
11.90
-11.35%
13.42
Selling General And Administration
74.92
+17.35%
63.84
-0.76%
64.33
+9.25%
58.89
Selling And Marketing Expense
43.92
+6.42%
41.27
+1.29%
40.74
+17.87%
34.56
General And Administrative Expense
31.01
+37.35%
22.57
-4.31%
23.59
-3.00%
24.32
Other Gand A
31.01
+37.35%
22.57
-4.31%
23.59
-3.00%
24.32
Other Operating Expenses
-2.25
-207.23%
-0.73
+72.37%
-2.65
-940.39%
-0.26
Total Expenses
184.62
+9.12%
169.18
+3.15%
164.01
-15.54%
194.18
Operating Income
-68.25
-497.47%
17.17
-63.95%
47.64
-27.92%
66.09
Total Operating Income As Reported
-70.51
-528.89%
16.44
-63.46%
44.99
-31.67%
65.83
EBITDA
-42.52
-199.81%
42.60
-40.91%
72.10
-15.73%
85.55
Normalized EBITDA
-42.33
-201.49%
41.71
-42.14%
72.10
-15.73%
85.55
Reconciled Depreciation
25.95
+7.42%
24.16
+1.05%
23.91
+27.19%
18.80
EBIT
-68.47
-471.39%
18.44
-61.74%
48.19
-27.82%
66.75
Total Unusual Items
-0.18
-120.83%
0.89
+108.84%
-10.05
-938.02%
-0.97
Total Unusual Items Excluding Goodwill
-0.18
-120.83%
0.89
+108.84%
-10.05
-938.02%
-0.97
Special Income Charges
—
—
-10.05
-938.02%
-0.97
Write Off
—
—
10.05
+938.02%
0.97
Net Income
-69.78
-716.96%
11.31
-64.04%
31.46
-32.69%
46.73
Pretax Income
-71.87
-599.33%
14.39
-67.11%
43.76
-31.53%
63.91
Net Non Operating Interest Income Expense
-3.30
+13.33%
-3.81
+7.27%
-4.11
-50.86%
-2.73
Interest Expense Non Operating
3.40
-15.90%
4.04
-8.59%
4.42
+55.79%
2.84
Net Interest Income
-3.30
+13.33%
-3.81
+7.27%
-4.11
-50.86%
-2.73
Interest Expense
3.40
-15.90%
4.04
-8.59%
4.42
+55.79%
2.84
Interest Income Non Operating
0.10
-58.44%
0.23
-25.96%
0.31
+173.68%
0.11
Interest Income
0.10
-58.44%
0.23
-25.96%
0.31
+173.68%
0.11
Other Income Expense
-0.32
-130.46%
1.03
+341.88%
0.23
-57.45%
0.55
Other Non Operating Income Expenses
-0.13
-189.04%
0.15
-37.61%
0.23
-57.45%
0.55
Gain On Sale Of Security
-0.18
-120.83%
0.89
—
—
Tax Provision
11.10
+1100.76%
0.92
-85.22%
6.25
-23.48%
8.17
Tax Rate For Calcs
0.00
+289.45%
0.00
-55.11%
0.00
+11.72%
0.00
Tax Effect Of Unusual Items
-0.05
-181.14%
0.06
0.00
0.00
Net Income Including Noncontrolling Interests
-82.97
-715.95%
13.47
-64.09%
37.51
-32.71%
55.74
Net Income From Continuing Operation Net Minority Interest
-69.78
-716.96%
11.31
-64.04%
31.46
-32.69%
46.73
Net Income From Continuing And Discontinued Operation
-69.78
-716.96%
11.31
-64.04%
31.46
-32.69%
46.73
Net Income Continuous Operations
-82.97
-715.95%
13.47
-64.09%
37.51
-32.71%
55.74
Minority Interests
13.18
+710.65%
-2.16
+64.33%
-6.05
+32.81%
-9.01
Normalized Income
-69.65
-764.55%
10.48
-66.68%
31.46
-32.69%
46.73
Net Income Common Stockholders
-69.78
-716.96%
11.31
-64.04%
31.46
-32.69%
46.73
Diluted EPS
—
0.24
-64.04%
0.67
-32.69%
0.99
Basic EPS
—
0.24
-65.19%
0.69
-32.69%
1.02
Basic Average Shares
—
47.17
+3.28%
45.67
+0.00%
45.67
Diluted Average Shares
—
47.17
+0.00%
47.17
+0.00%
47.17
Diluted NI Availto Com Stockholders
-69.78
-716.96%
11.31
-64.04%
31.46
-32.69%
46.73
Provision For Doubtful Accounts
1.44
+180.70%
-1.78
+52.02%
-3.71
-138.15%
9.73
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
436.47
-11.51%
493.25
-1.33%
499.89
-3.81%
519.67
Current Assets
137.42
-22.61%
177.57
-6.17%
189.24
-11.70%
214.31
Cash Cash Equivalents And Short Term Investments
51.89
+158.98%
20.04
+22.95%
16.30
+67.22%
9.75
Cash And Cash Equivalents
50.33
+170.54%
18.60
+23.43%
15.07
+54.66%
9.75
Cash Financial
50.33
+170.54%
18.60
+23.43%
15.07
+54.66%
9.75
Other Short Term Investments
1.56
+8.86%
1.43
+17.08%
1.22
0.00
Receivables
18.48
-78.29%
85.16
-14.35%
99.42
-25.94%
134.25
Accounts Receivable
18.48
-68.97%
59.56
-19.69%
74.17
-27.92%
102.90
Gross Accounts Receivable
36.52
-52.22%
76.44
-17.62%
92.78
-25.34%
124.28
Allowance For Doubtful Accounts Receivable
-18.03
-6.87%
-16.87
+9.36%
-18.62
+12.92%
-21.38
Other Receivables
—
2.63
+101.69%
1.30
+93.75%
0.67
Inventory
39.17
-32.73%
58.22
-0.14%
58.30
+5.19%
55.42
Raw Materials
7.93
+6.81%
7.43
-24.72%
9.87
-9.52%
10.91
Work In Process
17.69
-46.48%
33.05
-1.55%
33.57
-0.95%
33.89
Finished Goods
13.54
-23.65%
17.74
+19.37%
14.86
+6.26%
13.98
Prepaid Assets
21.10
+501.92%
-5.25
-268.81%
3.11
+27.83%
2.43
Current Deferred Assets
—
—
16.41
+31.76%
12.46
Restricted Cash
0.00
+0.00%
0.00
-99.98%
12.11
0.00
Other Current Assets
6.77
-65.09%
19.40
—
—
Total Non Current Assets
299.05
-5.27%
315.68
+1.62%
310.65
+1.73%
305.37
Net PPE
237.28
-7.01%
255.16
-3.07%
263.25
-4.35%
275.23
Gross PPE
369.06
+0.64%
366.72
+3.05%
355.85
+2.06%
348.65
Accumulated Depreciation
-131.78
-18.13%
-111.55
-20.47%
-92.60
-26.12%
-73.42
Properties
0.00
0.00
0.00
0.00
Land And Improvements
—
—
12.86
+0.00%
12.86
Buildings And Improvements
217.14
+5.70%
205.43
+4.17%
197.19
+64.62%
119.79
Machinery Furniture Equipment
3.28
+0.03%
3.28
+0.00%
3.28
-1.23%
3.32
Construction In Progress
0.61
-93.74%
9.75
+28.05%
7.62
-90.72%
82.06
Other Properties
148.03
-0.16%
148.26
+0.34%
147.76
+2.98%
143.48
Goodwill And Other Intangible Assets
54.76
+140.37%
22.78
-6.96%
24.48
-12.25%
27.90
Other Intangible Assets
54.76
+140.37%
22.78
-6.96%
24.48
-12.25%
27.90
Non Current Deferred Assets
0.00
-100.00%
19.04
+16.01%
16.41
—
Non Current Deferred Taxes Assets
0.00
-100.00%
10.99
-7.75%
11.91
—
Non Current Prepaid Assets
7.01
-62.49%
18.70
+187.48%
6.50
+191.14%
2.23
Total Liabilities Net Minority Interest
129.76
-7.78%
140.71
-12.40%
160.62
-1.35%
162.81
Current Liabilities
120.48
-11.35%
135.91
-9.54%
150.23
-1.31%
152.23
Payables And Accrued Expenses
49.35
+4.30%
47.31
-27.82%
65.55
-28.56%
91.75
Payables
48.85
+3.47%
47.21
-27.96%
65.54
-28.56%
91.74
Accounts Payable
44.01
+2.44%
42.96
-5.91%
45.66
-42.41%
79.28
Other Payable
2.49
+22.20%
2.04
+5.70%
1.93
-21.76%
2.47
Dividends Payable
—
0.00
-100.00%
15.65
0.00
Current Accrued Expenses
0.50
+402.02%
0.10
+890.00%
0.01
+0.00%
0.01
Total Tax Payable
2.35
+13.50%
2.07
-9.98%
2.29
-77.04%
10.00
Current Debt And Capital Lease Obligation
65.91
-19.27%
81.63
+2.22%
79.86
+45.49%
54.89
Current Debt
65.80
-19.40%
81.63
+2.22%
79.86
+45.49%
54.89
Other Current Borrowings
0.70
-90.26%
7.19
-91.00%
79.86
+45.49%
54.89
Current Capital Lease Obligation
0.11
0.00
—
—
Current Deferred Liabilities
4.83
-24.65%
6.41
+60.75%
3.98
-15.23%
4.70
Current Deferred Revenue
4.83
+30.99%
3.69
-7.53%
3.98
-15.23%
4.70
Other Current Liabilities
0.40
-28.60%
0.56
-33.89%
0.84
-5.08%
0.89
Total Non Current Liabilities Net Minority Interest
9.28
+93.35%
4.80
-53.77%
10.38
-1.86%
10.58
Long Term Debt And Capital Lease Obligation
9.18
+91.19%
4.80
-51.95%
9.99
+0.00%
9.99
Long Term Debt
8.85
+84.38%
4.80
-51.95%
9.99
+0.00%
9.99
Long Term Capital Lease Obligation
0.33
0.00
—
—
Tradeand Other Payables Non Current
—
0.00
-100.00%
0.39
-33.39%
0.59
Non Current Deferred Liabilities
0.10
0.00
—
—
Non Current Deferred Taxes Liabilities
0.10
0.00
—
—
Stockholders Equity
249.85
-12.01%
283.96
+4.07%
272.85
-7.98%
296.50
Common Stock Equity
249.85
-12.01%
283.96
+4.07%
272.85
-7.98%
296.50
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Share Issued
47.39
+0.48%
47.17
+0.00%
47.17
+0.00%
47.17
Ordinary Shares Number
47.39
+0.48%
47.17
+0.00%
47.17
+0.00%
47.17
Additional Paid In Capital
240.75
+18.51%
203.15
+0.00%
203.15
+0.00%
203.15
Retained Earnings
-21.63
-144.93%
48.15
+25.46%
38.38
-41.65%
65.77
Gains Losses Not Affecting Retained Earnings
30.72
-5.91%
32.65
+4.28%
31.31
+13.59%
27.57
Minority Interest
56.87
-17.08%
68.58
+3.25%
66.42
+10.02%
60.37
Other Equity Adjustments
30.72
-5.91%
32.65
+4.28%
31.31
+13.59%
27.57
Total Equity Gross Minority Interest
306.71
-13.00%
352.54
+3.91%
339.27
-4.93%
356.87
Total Capitalization
258.70
-10.41%
288.76
+2.09%
282.84
-7.72%
306.49
Working Capital
16.94
-59.33%
41.66
+6.80%
39.01
-37.17%
62.08
Invested Capital
324.50
-12.39%
370.39
+2.12%
362.70
+0.37%
361.38
Total Debt
75.08
-13.13%
86.43
-3.80%
89.85
+38.49%
64.88
Net Debt
24.32
-64.15%
67.83
-9.29%
74.78
+35.63%
55.13
Capital Lease Obligations
0.43
0.00
—
—
Net Tangible Assets
195.09
-25.30%
261.18
+5.16%
248.37
-7.53%
268.59
Tangible Book Value
195.09
-25.30%
261.18
+5.16%
248.37
-7.53%
268.59
Current Deferred Taxes Assets
—
—
11.91
-4.34%
12.46
Duefrom Related Parties Current
0.00
0.00
-100.00%
0.74
0.00
Dueto Related Parties Current
0.00
-100.00%
0.15
0.00
—
Inventories Adjustments Allowances
—
—
-13.39
-298.42%
-3.36
Line Of Credit
65.10
-12.55%
74.44
-6.78%
79.86
—
Notes Receivable
0.00
-100.00%
25.59
+10.24%
23.21
-24.33%
30.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
13.33
-67.52%
41.05
-14.81%
48.18
+177.96%
17.34
Cash Flow From Continuing Operating Activities
13.33
-67.52%
41.05
-14.81%
48.18
+177.96%
17.34
Net Income From Continuing Operations
-82.97
-715.95%
13.47
-64.09%
37.51
-32.71%
55.74
Depreciation Amortization Depletion
25.95
+7.42%
24.16
+1.05%
23.91
+27.19%
18.80
Depreciation
25.95
+7.42%
24.16
+1.05%
23.91
—
Depreciation And Amortization
25.95
+7.42%
24.16
+1.05%
23.91
+27.19%
18.80
Other Non Cash Items
—
—
—
—
Provisionand Write Offof Assets
1.44
+180.70%
-1.78
+52.02%
-3.71
-138.15%
9.73
Asset Impairment Charge
12.80
+114.71%
5.96
-40.53%
10.03
+935.74%
0.97
Deferred Tax
11.10
+1100.76%
0.92
+70.79%
0.54
+141.27%
-1.31
Deferred Income Tax
11.10
+1100.76%
0.92
+70.79%
0.54
+141.27%
-1.31
Operating Gains Losses
0.31
+161.78%
-0.51
-370.05%
0.19
—
Unrealized Gain Loss On Investment Securities
-0.13
+39.23%
-0.21
0.00
0.00
Net Foreign Currency Exchange Gain Loss
0.31
+145.95%
-0.68
0.00
0.00
Gain Loss On Sale Of PPE
0.00
-100.00%
0.17
-6.95%
0.19
0.00
Change In Working Capital
44.83
+4688.23%
-0.98
+95.18%
-20.28
+69.55%
-66.60
Change In Receivables
61.41
+387.64%
12.59
-67.39%
38.62
+181.51%
-47.37
Changes In Account Receivables
39.71
+142.94%
16.34
-47.35%
31.04
+225.56%
-24.72
Change In Inventory
6.25
+206.29%
-5.88
+54.41%
-12.90
-4.68%
-12.32
Change In Prepaid Assets
-21.33
-138.02%
-8.96
-658.04%
-1.18
-64.85%
-0.72
Change In Payables And Accrued Expense
-2.67
-259.45%
1.67
+103.79%
-44.09
-578.37%
-6.50
Change In Accrued Expense
0.42
-84.54%
2.70
+563.57%
-0.58
-381.16%
0.21
Change In Payable
-3.08
-200.49%
-1.03
+97.64%
-43.51
-548.76%
-6.71
Change In Account Payable
-3.36
-732.18%
-0.40
+98.87%
-35.61
-268.17%
-9.67
Change In Other Working Capital
1.27
+416.75%
-0.40
+44.06%
-0.71
-325.55%
0.32
Change In Other Current Liabilities
-0.11
0.00
0.00
+100.00%
-0.20
Investing Cash Flow
-12.63
+54.35%
-27.66
-135.15%
-11.77
+56.95%
-27.33
Cash Flow From Continuing Investing Activities
-12.63
+54.35%
-27.66
-135.15%
-11.77
+56.95%
-27.33
Net PPE Purchase And Sale
-1.01
+92.52%
-13.48
-112.70%
-6.34
+76.81%
-27.33
Purchase Of PPE
-1.01
+92.58%
-13.59
-83.71%
-7.40
+72.94%
-27.33
Sale Of PPE
0.00
-100.00%
0.11
-89.80%
1.06
0.00
Capital Expenditure
-12.63
+54.52%
-27.77
-139.42%
-11.60
+57.55%
-27.33
Net Investment Purchase And Sale
0.00
0.00
+100.00%
-1.22
0.00
Purchase Of Investment
0.00
0.00
+100.00%
-1.22
0.00
Net Intangibles Purchase And Sale
-11.62
+18.07%
-14.19
-237.44%
-4.20
0.00
Purchase Of Intangibles
-11.62
+18.07%
-14.19
-237.44%
-4.20
0.00
Financing Cash Flow
32.31
+246.01%
-22.13
-16.60%
-18.98
-241.06%
13.46
Cash Flow From Continuing Financing Activities
32.31
+246.01%
-22.13
-16.60%
-18.98
-241.06%
13.46
Net Issuance Payments Of Debt
-12.09
-341.71%
-2.74
-110.97%
24.97
-28.41%
34.88
Issuance Of Debt
70.47
-21.81%
90.12
+12.85%
79.86
-20.02%
99.85
Repayment Of Debt
-82.56
+11.09%
-92.86
-69.17%
-54.89
+15.52%
-64.97
Long Term Debt Issuance
70.47
-21.81%
90.12
+12.85%
79.86
-20.02%
99.85
Long Term Debt Payments
-82.56
+11.09%
-92.86
-69.17%
-54.89
+15.52%
-64.97
Net Long Term Debt Issuance
-12.09
-341.71%
-2.74
-110.97%
24.97
-28.41%
34.88
Net Common Stock Issuance
43.08
0.00
0.00
—
Common Stock Dividend Paid
0.00
+100.00%
-16.02
+59.39%
-39.45
-84.14%
-21.43
Cash Dividends Paid
0.00
+100.00%
-16.02
+59.39%
-39.45
-84.14%
-21.43
Net Other Financing Charges
1.32
+139.31%
-3.37
+25.11%
-4.50
—
Changes In Cash
33.01
+477.38%
-8.75
-150.16%
17.44
+403.76%
3.46
Effect Of Exchange Rate Changes
-1.28
-864.88%
0.17
0.00
0.00
Beginning Cash Position
18.61
-31.56%
27.19
+178.95%
9.75
+55.09%
6.28
End Cash Position
50.33
+170.53%
18.61
-31.56%
27.19
+178.95%
9.75
Free Cash Flow
0.70
-94.70%
13.27
-63.72%
36.58
+466.10%
-9.99
Interest Paid Supplemental Data
3.36
-15.78%
3.98
-9.90%
4.42
+55.79%
2.84
Income Tax Paid Supplemental Data
0.00
-100.00%
0.12
-98.89%
10.49
+23.64%
8.48
Change In Income Tax Payable
0.28
+221.83%
-0.23
+97.03%
-7.70
-341.37%
3.19
Change In Tax Payable
0.28
+221.83%
-0.23
+97.03%
-7.70
-341.37%
3.19
Common Stock Issuance
43.08
0.00
0.00
—
Issuance Of Capital Stock
43.08
0.00
0.00
—
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category